Radiation induced mucositis: Co-ordinating a research agenda

Clinical Oncology

Volumn 15, Issue 8, 2003, Pages 473-477

  Wright, Jim R ^a,b   McKenzie, M ^c,d   DeAngelis, C ^e   Foroudi, F ^f   Paul, N ^g   Rajaraman, M ^h   Wong, F ^c   Wong, R ^a,b   Wong, K S R ^i,j  

^a CANCER CARE ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f Kingston Regional Cancer Center   (Canada)

^g Queen's Cancer Research Institute   (Canada)

^h Nova Scotia Cancer Center   (Canada)

ⁱ PRINCESS MARGARET HOSPITAL   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Clinical research; Clinical trials; Radiation mucositis; Symptom control; Toxicity scoring

Indexed keywords

AMIFOSTINE; ANTIFUNGAL AGENT; BENZYDAMINE; DIPHENHYDRAMINE; LIDOCAINE; NYSTATIN; STEROID; SUCRALFATE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ESOPHAGITIS; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDICAL SPECIALIST; MOUTHWASH; MUCOSA INFLAMMATION; ONCOLOGICAL PARAMETERS; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION INJURY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; WORKSHOP;

EID: 0344825330     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2003.07.002     Document Type: Article

References (26)

1. Bensadoun R, Magne N, Marcy P, et al. Chemotherapy and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment. Oncology 2001;258:481-487.
2. Robbins K. Barriers to winning the battle with head and neck cancer. Int J Radiat Oncol Biol Phys 2002;53:4-5.
3. Denham JW, Walker QJ, Lamb DS, et al. Mucosal regeneration during radiotherapy. Radiother Oncol 1996;41:109-118.
4. Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nurs 2001;24:241-253.
5. Foote RL, Loprinzi CL, Frank AR. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation induced mucositis. J Clin Oncol 1994;12:2630-2633.
6. Leborgne J, Leborgne F, Zubizarreta E. Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial. Radiother Oncol 1997;47: 145-148.
7. Sprinzl GM, Galvan O, de Vries A, et al. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. Eur J Cancer 2001;37:1971-1975.
8. Wijers O, Levendag PC, Harms E, et al. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a Placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 2001;50:343-352.
9. El-Sayd S, Epstein J, Minish E, et al. A pilot study evaluating the safety and microbiologic efficacy of an economically viable anti-microbial lozenge in patients with head and neck cancer receiving radiation therapy. Head Neck 2002;24:6-15.
10. Franzen L, Henriksson R, Littbrand B, et al. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. a double-blind placebo-controlled study. Acta Oncol 1995;34:219-223.
11. Epstein JB, Silverman S Jr., Paggiarino DA, et al. Benzydamine HC1 for prophylaxis of aradiation-induced oral mucositis. Cancer 2001;92:875-885.
12. Antonadou D, Pepelassi M, Synodinou M, et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer. Int J Radiat Oncol Biol Phys 2002;52:739-747.
13. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-3345.
14. Gujral MS, Patnaik PM, Kaul R, et al. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol 2001;47:23-28.
15. Bensadoun RJ, Franquin JC, Ciais G, et al. Low-energy He/Ne laser in the Prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 1999;7:244-252.
16. Adamietz IA, Rahn R, Bottcher HD, et al. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy. Support Care Cancer 1998;6:331.
17. Sutherland SE, Browman GP. Prophylaxis of oral mucositis in irradiated head and neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials. Int J Radiat Oncol Biol Phys 2001;49:917-930.
18. Parulekar W, MacKenzie R, Bjarnason G, et al. Scoring oral mucositis. Oral Oncol 1998;34:63-71.
19. Sonis ST, Eilers J, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999;85:2103-2113.
20. Dodd MJ. Defining clinically meaningful outcomes in the evaluation of the new treatments for oral mucositis: a commentary. Cancer Investig 2002;20(5/6):851-852.
21. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionannaire-H&N35. J Clin Oncol 1999;17:1008.
22. List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A ztudy of utility and validity. Cancer 1996;77:2294-2301.
23. Browman GP, Levine MN, Hodson DI, et al. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality of life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993;11:863-872.
24. Leveque FG, Montgomery M, Potter D. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993;11:1124-1131.
25. Wagner W, Prott FJ, Schonekas KG. Amifostine: a radioprotector in locally advanced head and neck tumors. Oncol Rep 1998;5: 1255-1257.
26. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer. Int J Radiat Oncol Biol Phys 2002; 54:719-728.